ALC:NYSE
Alcon AG
70,04 US$
arrow_downward
-0,18%(-0,12) 1K
26-okt, 11:42:42 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
70,08 US$
Yuqori
70,45 US$
Past
69,70 US$
Bozor kapitali
29,08 mlrd
Oʻrtacha hajm
1,79 mln
Hajmi
637,69 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Ochish
70,08 US$
Yuqori
70,45 US$
Past
69,70 US$
Bozor kapitali
29,08 mlrd
Oʻrtacha hajm
1,79 mln
Hajmi
637,69 ming
52 haftalik eng yuqori
87,64 US$
52 haftalik eng past
61,84 US$
Beta
0,88
Muomaladagi aksiyalar
483,40 mln
Xodimlar soni
25 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Barchart.com
·
15 daqiqa oldin
Jeff Bezos Says He’d Tell Retirees to Buy the S&P 500 Over AI Stocks — ‘Hard For Investors To Know The Difference Between Good Ideas And Bad Ideas’
CNBC
·
6 daqiqa oldin
Investors are doing just as well this year by shunning AI. How to invest if the tech trade keeps fizzling
SEC.gov
·
2 soat oldin
Anthropic, PBC - S-1 (Q2)
Nasdaq
·
1 soat oldin
BNB Standard Corporation Rings the Opening Bell
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25 ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com